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One of the most promising advantages for health information exchange (HIE) is improved patient safety. Up to 18% of the patient
safety errors generally and as many as 70% of adverse drug events could be eliminated if the right information about the right patient is
available at the right time. Health information exchange makes this possible.
Here we present an overview of six diﬀerent ways in which HIE can improve patient safety—improved medication information pro-
cessing, improved laboratory information processing, improved radiology information processing, improved communication among pro-
viders, improved communication between patients and providers, and improved public health information processing. Within the area of
improved medication information processing we discuss drug-allergy information processing, drug–dose information processing, drug–
drug information processing, drug-diagnosis information processing, and drug–gene information processing. We also brieﬂy discuss HIE
and decreased patient safety as well as standards and completeness of information for HIE and patient safety.
 2007 Elsevier Inc. All rights reserved.
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Among the many potential advantages of health infor-
mation exchange (HIE), patient safety stands out as one
of the most promising. Healthcare is an information rich
environment which requires many pieces of information
for even the simplest healthcare decisions. As the Institute
of Medicine’s 2000 To Err is Human report underscored,
iatrogenic causes of injuries are frequent, and they repre-
sent an important cause of death among patients, with an
estimated 44,000–98,000 deaths per year [1]. Patient safety
can be eroded by both errors of commission and errors of
omission if the right information is not available to the
right person at the right time. As care is delivered in the
US today, information gaps represent the rule rather than
the exception.1532-0464/$ - see front matter  2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.jbi.2007.08.011
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E-mail address: dbates@partners.org (D.W. Bates).Better patient safety through enhanced, technology
enabled, HIE will directly improve patient safety because
it will provide a more complete clinical picture of a patient.
A signiﬁcant evidence base already exists showing that HIE
can improve patient safety in a number of areas, although
in practice robust HIE today is only occurring in a small
number of institutions a small proportion of the time.
However, patient safety can be improved using health
information technology (HIT) even without interoperabil-
ity, though HIE can be expected to substantially potentiate
the eﬀect of HIT.
HIE can be thought of both in terms of who the exchange
is between and what the type health information exchanged
is (Fig. 1) [2]. Usually, the more people and more informa-
tion involved in the HIE, the more valuable the exchange
will be for patient safety. Up to 18% of patient safety errors
have been estimated to have occurred because the appropri-
ate information was not available at the time the medication
decision was made [3]. For example, of the estimated
770,000 adverse drug events (ADEs) that occur each year
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Fig. 1. Two-dimensional view of healthcare information exchange and
patent safety. Level 1—phone and mail health information exchange.
Level 2—machine transportable data (standard fax). Level 3—machine
organizable data (e-mail and electronic messaging). Level 4—machine
interpretable data (interoperable data exchange with standardized formats
and content) [2]. (A) Historical health information exchange paradigm
with individual isolated providers not exchanging any information. (B)
Relatively common current paradigm with many providers exchanging
generally paper records among themselves. (C) Increasing common
paradigm with some providers exchanging electronic health information
among themselves. (D) Ideal future state in which all providers are
exchanging robust electronic health information leading to improvements
in patient safety.
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be preventable [7–9]. Below we will discuss a variety of areas
in which HIE can impact patient safety (Fig. 2).2. Health information exchange and increased patient safety
2.1. Improved medication information processing
With regard to patient safety, medication information
processing probably represents the most studied area of
HIE today. While the exact ﬁgure is uncertain, one study
has estimated that over 100,000 deaths occur annually in
the United States because of adverse drug events (ADEs),
including both non-preventable and preventable ADEs
[4]. In most large safety studies, ADEs have been the most
common cause of iatrogenic illness; they appear to occur in
about 5–15% of therapeutic drug courses [10]. AlthoughImproved Patient Safety Opportunities Through Health 
Information Exchange (HIE) 
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Fig. 2. List of areas of improved patient safety from enhanced health
information exchange (HIE).most of these ADEs will not be amenable to elimination
with improved HIE, an important proportion will, and
many opportunities and strategies that improve patient
safety through HIE have been studied. We will divide
HIE’s impact on medication information processing into
ﬁve subsections below.
2.1.1. Drug-allergy information processing
One of the most obvious forms of medication informa-
tion processing for patient safety is drug-allergy processing.
This involves checking drugs against known patient-spe-
ciﬁc drug allergies before the drugs are given to the patient.
Up to 30% of people mention a drug allergy when asked
and up to 10% of ADEs are thought to involve signiﬁcant
allergic reactions [11–13].
Some particular characteristics of eﬀective drug-allergy
checking make it very amenable to improved HIE. First
of all, a complete list of all patient allergic reactions and
medications must be available. Second, details of the cir-
cumstances of the possible allergic reaction and possible
medication(s) should be accessible. Determining the exact
circumstances can be particularly complicated as many
reported allergic reactions occurred years or even decades
before the current medication decision. Typically the
patient is relied upon as the source of allergic reaction
and causal agent(s), however up to 50% of patient reported
medication related allergic reactions are thought not to be
true allergic reactions [11]. More robust HIE could greatly
reduce the frequency of ADEs from known allergic reac-
tions, by ﬁnding prior allergies that the patient may not
have remembered, and by improving the accuracy of the
allergy list.
2.1.2. Drug–dose information processing
Dosing errors represent the most common type of med-
ication error leading to preventable ADEs and account for
up to 60% of prescribing errors [3,7,14–21]. Drug–dose
information processing helps improve patient safety by
helping to ensure that the individual dose, daily dose,
and total dose will minimize toxicity while providing ther-
apeutic eﬃcacy. At the most basic level, drug–dose infor-
mation processing involves being sure that the individual
dose, dosing frequency, and total duration of medication
fall within accepted general standards. At a more advanced
level, drug–dose information processing can take into
account patient-speciﬁc information such as patient age
(geriatric dosing), weight (pediatric dosing), and creatinine
clearance (renal dosing).
Drug–dose information processing has been shown to
improve patient safety in a number of settings. For exam-
ple, renal dosing of medications is perhaps the single most
important piece of decision support, and when dosing is
based on the patient’s renal function it is more often appro-
priate; in one study, hospitalized patients’ length of stay
decreased [22]. Also, more appropriate geriatric dosing of
psychotropic medications decreased falls among the elderly
in the inpatient setting [23]. Antibiotic-related decision
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on a number of parameters, has signiﬁcantly decreased
adverse drug event rates, as well as cost and days of unnec-
essary therapy [24]. With respect to interoperability, renal
dosing will probably be especially important, as the
patient’s level of kidney function should be available for
dosing decisions in all settings.
2.1.3. Drug–drug information processing
The most robust medication information processing cur-
rently occurs at the drug–drug level. This support can sig-
niﬁcantly improve patient safety, but it will be most
eﬀective only if the entire list of all of a patient’s medica-
tions, including over the counter medications, herbal med-
ications, and supplements, are available at the time of
medication prescription and administration.
Drug–drug information processing generally takes three
forms. The most commonly thought of involves adding an
additional medication(s) to a patient’s other medications,
which might then cause a known side eﬀect, in which case
the new or existing medications might be changed in order
to prevent the adverse drug event.
A second type of drug–drug information processing
involves duplicate pharmacological class checking.
Although therapeutic duplication accounts for less than
6% of adverse drug events, improvements in this area will
also beneﬁt patient safety and are enhanced by improved
HIE [3,7,16].
A third type of drug–drug information processing for
patient safety occurs when one medication is being added
that could indicate the addition of another medication
for improved patient safety. For example, patient safety
is improved when chronic non-steroidal anti-inﬂammatory
drugs (NSAIDS) are using in conjunction with proton
pump inhibitors (PPIs) [25–27] or probiotics are used in
association with antibiotics [28]. This erosion of patient
safety due to lack of appropriate use of synergistic medica-
tions has also been well documented in AIDS patients on
HAART [29–31].
2.1.4. Drug-diagnosis information processing
Drug-diagnosis (drug–disease) information processing is
an expanding area in which enhanced HIE has the poten-
tial to improve patient safety. In some ways an outgrowth
of patient-speciﬁc drug–dose information processing, drug-
diagnosis information processing takes into account medi-
cal conditions and contraindications that would aﬀect drug
dosing or administration at all. These reasons for problems
in patient safety are known to occur and cause morbidity
and morbidity [32–34].
Examples of diagnoses that would aﬀect drug choice or
dosing range from pregnancy and breast feeding to hepatic
impairment in people with cirrhosis. Additional speciﬁc
examples include not prescribing non-selective b-blockers
to someone with asthma, giving streptokinase to someone
with a recent bleed, and various medication contraindica-
tions in people with myasthenia gravis, glaucoma, and pro-longed QT intervals. The British National Formulary
shows approximately 1500 contraindications between
drugs/drug groups and various morbidities and clinical
states [35].
A next-generation drug-diagnosis information process-
ing system might also check to see if the drug being pre-
scribed is indicated for any of a patient’s diagnoses. This
would help eliminate inappropriate sound-alike/look-alike
medications from being prescribed such as clonidine and
klonopine. Drug-diagnosis information processing will
optimize patient safety only in an environment in which
HIE allows all of a patients’ diagnoses to be available at
the time of drug prescribing and administration.
2.1.5. Drug–gene information processing
Although not currently a reality, as gene analysis
becomes more proliﬁc and pharamocogenomics becomes
more developed, the ability to interchange drug informa-
tion and patient-speciﬁc genomic information will become
increasing important for patient safety. HIE in this area
has the potential to optimize pharmaceutical choices to
avoid/reduce ADEs and other side eﬀects, as well as opti-
mize eﬀectiveness [36].
2.2. Improved laboratory information processing
Patient safety can also be improved by enhanced labora-
tory information processing enabled by HIE. The two pri-
mary areas for this include (1) helping to ensure that
indicated lab testing is ordered and (2) helping to guarantee
that lab test results (especially abnormal results) are appro-
priately followed up on. HIE is particularly critical in this
process in this era of few in-oﬃce tests, many ‘‘send-out’’
tests, and numerous independent laboratories.
A prime example of the interplay between laboratory
information processing and patient safety is in the area
of medications. Dozens of commonly used medication
require labs prior to initiation and/or after initial adminis-
tration to monitor for patient safety [35,37]. Unfortunately,
many studies document inappropriate laboratory informa-
tion processing [38–44]. Other examples in this area include
appropriate ordering and follow-up of Pap smears, pros-
tate-speciﬁc antigen (PSA) levels, cholesterol levels, and
stool guiaic testing, to name a few. Improved HIA could
improve patient safety in this area.
2.3. Improved radiology information processing
Typically the provider ordering an imaging study is dif-
ferent from the provider interpreting the imaging study.
Therefore, health information has to be exchanged between
these two health professionals for the radiology study to be
eﬀectively ordered and interpreted. Patient safety can be
enhanced in both of these areas of radiology information
processing through improved HIE.
For example, improved HIE could decrease adverse
intravenous contrast reactions and decrease exposure to
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tion exposure [46]. Probably more important for patient
safety is improvement in HIE to ensure appropriate fol-
low-up of abnormal radiology ﬁndings. For instance, up
to 2% of abnormal mammograms were found to be lost
to follow-up without enhanced information exchange [47].
2.4. Improved communication among providers
Every year each patient has, on average, four outpatient
visits with just over half of these visits being to primary
care providers, approximately 40% to specialists, and
approximately 10% to emergency departments [48]. In
addition, there are 114 hospital discharges per 1000 people
per year [49]. The result of these healthcare interactions is
that many providers (physicians and others) are involved
with each patient every year. Although many of these inter-
actions are for acute/subacute issues, each of these encoun-
ters can provide valuable information for the patient’s
future care. Also, when diﬀerent primary care providers
and/or subspecialists are managing diﬀerent medical issues,
eﬀective information sharing is critical, but does not always
occur.
Many healthcare scenarios exist in which patient safety
is jeopardized because of lack of HIE among providers.
Patients routinely present to emergency departments out-
side of their normal healthcare system, sometimes unable
to communicate, where their providers may have little or
no prior information about them [50]. Providers who do
not know the patient, either in an inpatient or outpatient
setting, make safer decisions with improved HIE [51,52].
Surgeries present times when many signiﬁcant decisions
and changes in patient care occur, involving many provid-
ers, in a relatively short period and can result in signiﬁ-
cant erosion of patient safety. Changes in location of
care—for instance hospitals to home or nursing home set-
tings—also present opportunities for HIE to improve
patient safety [53]. The Joint Commission on Accredita-
tion of Healthcare Organizations in their medications
across the continuum standard and others, have identiﬁed
patient hand-oﬀs as a key point of breakdown in patient
safety.
2.5. Improved communication between patients and providers
In general, no one should be more invested in their own
healthcare safety then patients themselves. In our current
healthcare paradigm, however, minimal HIE occurs with
patients and healthcare organizations typically do not suf-
ﬁciently recognize the key role that patients can play in
ensuring their own healthcare safety. With the signiﬁcant
interest and impending growth of improved HIE with
patients through personal health records (PHRs), many
hope this paradigm will change.
There are many ways in which HIE can improve patient
safety through enhanced patient–provider communication.
Examples include patients checking for errors in their med-ical history, adding additional valuable information into
their medical records, following up on their own test
results, reviewing medications and other healthcare instruc-
tions, and being able to communicate more quickly with
healthcare providers when they think their safety may be
at risk. PHRs may also allow providers to more quickly
and more accurately provide information to their patients,
which should improve patient safety.
Because PHRs are in their infancy, improved patient
safety through HIE facilitated by a PHR has not been
proven, although interest is high. Sixty-nine percent
(69%) of patients indicate that they would look for errors
in their medical record if a PHR allowed this [54]. Sixty-
three percent (63%) of patients would track their test
results [54]. Sixty-ﬁve percent (65%) of patients would
transfer information to a new healthcare provider through
a PHR if they could [54]. All of this increased patient to
provider exchange should improve patient safety. Over
60% of people feel that PHRs will help prevent medical
mistakes [54].
2.6. Improved public health information processing
A rapidly growing area of HIE is public health infor-
matics. Patient safety could be greatly enhanced through
this growth. Opportunities for improved patient safety in
this area include post-marketing drug surveillance, infec-
tious disease surveillance, biohazard surveillance, and envi-
ronmental exposure surveillance. For instance, in 2006 the
Centers for Disease Control recommended expanding the
age for childhood inﬂuenza vaccination based on enhanced
public health informatics HIE [55].
3. Health information exchange and decreased patient safety
Although the overwhelming evidence points to improve-
ment in patient safety with health information technology
(HIT), some studies appear to have shown degradation in
patient safety with increased use of HIT, although these
studies did not focus speciﬁcally on HIE [56,57]. These
post-implementation studies tried to evaluate the eﬀect on
patient safety of electronic medical record systems and spe-
ciﬁcally computerized physician order entry. Careful
review of these studies and attempts to replicate these stud-
ies highlighted unusual circumstances that appear, in the
Han study, to have led to the increase in morbidity and
mortality reported [58,59]. However, these studies do typify
the fact that increasing use of HIT alone does not lead to
superior patient safety. Rather, for improved patient
safety, healthcare systems must be organized to facilitate
eﬀective use of their HIT [60,61].
Increasing the level of HIE could reduce patient safety
in a variety of ways, for example, if incorrect patient-spe-
ciﬁc information were made available to providers, if one
patient’s information was believed to be that of another,
if there were errors in translating information between
one system and others or if implementation of HIE slowed
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safety. Those who are evaluating HIE should be alert to
these and other unintended consequences of implementa-
tion of HIE.4. Standards for health information exchange and patient
safety
For robust, eﬃcient HIE, standards must be developed
dictating the type and content of information to be
exchanged. A prototypical example of this is the near ubiq-
uitous proliferation of PACS (Picture Archive and Com-
munication Systems) standards within the ﬁeld of
radiology. Allergy, medication, laboratory, diagnosis, and
notes messaging standards must be developed and imple-
mented with a similar degree of rigor in order for equiva-
lent HIE in these other areas to yield similar results.5. Completeness of information for health information
exchange and patient safety
Another challenge is the completeness of the HIE. As
electronic HIE increases, health professionals run the risk
of assuming that all information is being exchanged and
everyone is having their information exchanged. Systems
currently in place for dealing with paper records and/or
dealing with people who opt-out of HIE networks (for
instance Regional Health Information Organizations
(RHIOs)) may not continue. Therefore, our ability to pro-
cess health information in patients who have some health
information that is not readily exchanged and/or to deal
with patients who do not want their information exchanged
may decrease and these patients could potentially see their
patient safety eroded.6. Conclusions
As more and more health care information becomes dig-
ital, the potential for HIE to improve patient safety will
grow, and it is already robust. One challenge will be to
develop healthcare systems capable of processing and uti-
lizing the dramatic increase in information. Only then will
the potential of improved patient safety through enhanced
HIE be realized because we will have increased the percent-
age of time that the right information is presented to the
right person at the right time so that the right healthcare
decision can be made.Acknowledgments
The authors have no acknowledgements. There was no
funding organization or sponsors involved in any aspect
of this research. The authors have no ﬁnancial or commer-
cial relationships that may pose a conﬂict of interest.References
[1] Kohn L, Corrigan J, Donaldson M, editors. To Err Is Human:
Building a Safer Health System. Washington DC: Institute of
Medicine, National Academy Press; 2000.
[2] Walker J, Pan E, Johnston D, Adler-Milstein J, Bates DW,
Middleton B. The value of healthcare information exchange and
interoperability. Hlth Aﬀ (Millwood) 2005 Jan–Jun;Suppl Web
Exclusives:W5-10-W5-18.
[3] Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan
T, et al. Systems analysis of adverse drug events. ADE Prevention
Study Group. JAMA 1995;274(1):35–43.
[4] Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug
reactions in hospitalized patients: a meta-analysis of prospective
studies. JAMA 1998;279(15):1200–5.
[5] Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse
drug events in hospitalized patients. Excess length of stay, extra costs,
and attributable mortality. JAMA 1997;277(4):301–6.
[6] Cullen DJ, Sweitzer BJ, Bates DW, Burdick E, Edmondson A, Leape
LL. Preventable adverse drug events in hospitalized patients: a
comparative study of intensive care and general care units. Crit Care
Med 1997;25(8):1289–97.
[7] Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D,
et al. Incidence of adverse drug events and potential adverse drug
events. Implications for prevention. ADE Prevention Study Group.
JAMA 1995;274(1):29–34.
[8] Raschke RA, Gollihare B, Wunderlich TA, Guidry JR, Leibowitz AI,
Peirce JC, et al. A computer alert system to prevent injury from
adverse drug events: development and evaluation in a community
teaching hospital. JAMA 1998;280(15):1317–20.
[9] Leape LL. Error in medicine. JAMA 1994;272(23):1851–7.
[10] Jick H. Adverse drug reactions: the magnitude of the problem. J
Allergy Clin Immunol 1984;74(4 Pt 2):555–7.
[11] Hung OR, Bands C, Laney G, Drover D, Stevens S, MacSween M.
Drug Allergies in the surgical population. Can J Anaesth
1994;41(12):1149–55.
[12] deShazo RD, Kemp SF. Allergic reactions to drugs and biologic
agents. JAMA 1997;278(22):1895–906.
[13] Anderson JA, Adkinson NF. Allergic reactions to drugs and biologic
agents. JAMA 1987;258(20):2891–9.
[14] Kaushal R, Bates DW, Landrigan C, McKenna KJ, Clapp MD,
Federico F, et al. Medication errors and adverse drug events in
pediatric inpatients. JAMA 2001;285(16):2114–20.
[15] Lesar TS, Briceland L, Stein DS. Factors related to errors in
medication prescribing. JAMA 1997;277(4):312–7.
[16] Lesar TS, Briceland LL, Delcoure K, Parmalee JC, Masta-Gornic V,
Pohl H. JAMA 1990;263(17):2329–34.
[17] Gandhi TK, Weingart SN, Seger AC, Borus J, Burdick E, Poon EG,
et al. J Gen Intern Med 2005;20(9):837–41.
[18] Bobb A, Gleason K, Husch M, Feinglass J, Yarnold PR, Noskin GA.
The epidemiology of prescribing errors: the potential impact of
computerized prescriber order entry. Arch Intern Med
2004;164(7):785–92.
[19] Folli HL, Poole RL, Benitz WE, Russo JC. Medication error
prevention by clinical pharmacists in two children’s hospitals.
Pediatrics 1987;79(5):718–22.
[20] Kozer E, Scolnik D, Keays T, Shi K, Luk T, Koren G. Large errors
in the dosing of medications for children. N Engl J Med
2002;346(15):1175–6.
[21] Lesar TS. Tenfold medication dose prescribing errors. Ann Phar-
macother 2002;36(12):1833–9.
[22] Chertow GM, Lee J, Kuperman GJ, Burdick E, Horsky J, Seger DL,
et al. Guided medication dosing for inpatients with renal insuﬃ-
ciency. JAMA 2001;286(22):2839–44.
[23] Peterson JF, Kuperman GJ, Shek C, Patel M, Avorn J, Bates DW.
Guided prescription of psychotropic medications for geriatric inpa-
tients. Arch Intern Med 2005;165(7):802–7.
D.C. Kaelber, D.W. Bates / Journal of Biomedical Informatics 40 (2007) S40–S45 S45[24] Evans RS, Pestonik SL, Classen DC, Clemmer TP, Weaver LK,
Orme Jr JF, et al. A computer-assisted management program for
antibiotics and other antiinfective agents. N Engl J Med
1998;338(4):232–8.
[25] Goldstein JL, Howard KB, Walton SM, McLaughlin TP, Kruzikas
DT. Impact of adherence to concomitant gastroprotective therapy on
nonsteroidal-related gastroduodenal ulcer complications. Clin Gas-
troenterol Hepatol 2006;4(11):1337–45.
[26] Brown TJ, Hooper L, Elliott RA, Payne K, Webb R, Roberts C,
et al. A comparison of the cost-eﬀectiveness of ﬁve strategies for the
prevention of non-steroidal anti-inﬂammatory drug-induced gastro-
intestinal toxicity: a systematic review with economic modelling.
Health Technol Assess 2006;10(38). p. iii–iv, xi–xiii, 1–183.
[27] Rostom A, Wells G, Tugwell P, Welch V, Dube C, McGowan J.
Prevention of chronic NSAID induced upper gastrointestinal toxic-
ity. Cochrane Database Syst Rev 2000(3):CD002296.
[28] D’Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in
prevention of antibiotic associated diarrhoea: meta-analysis. BMJ
2002;324(7350):1361.
[29] Faragon JJ, Lesar TS. Update on prescribing errors with HAART.
AIDS Read 2003;13(6):268–70. 274–8.
[30] Purdy BD, Lesar TS. Antiretroviral medication errors for patients
with HIV infection. AIDS Read 1999;9(6):414–9.
[31] Purdy BD, Raymond AM, Lesar TS. Antiretroviral prescribing errors
in hospitalized patients. Ann Pharmacother 2000;34(7–8):833–8.
[32] Howard RL, Avery AJ, Howard PD, Partridge M. Investigation into
the reasons for preventable drug related admissions to a medical
admissions unit: observational study. Qual Saf Health Care
2003;12(4):280–5.
[33] Klaukka T, Makela M, Sipila J, Martikainen J. Multiuse of
medicines in Finland. Med Care 1993;31(5):445–50.
[34] Sipila J, Klaukka T, Martikainen J, Himberg J. Occurrence of
potentially harmful drug combinations among Finish primary care
patients, Int Pharm J 1995;1995 (9):104–10.
[35] Chen YF, Avery AJ, Neil KE, Johnson C, Dewey ME, Stockley IH.
Incidence and possible causes of prescribing potentially hazardous/
contraindicated drug combinations in general practice. Drug Saf
2005;28(1):67–80.
[36] Evans WE, McLeod HL. Pharmacogenomics—drug disposition,
drug targets, and side eﬀects. N Engl J Med 2003;348(6):538–49.
[37] J.F. Committee, British National Formulary 49th Edition. 2005,
British Medical Association and Royal Pharmaceutical Society of
Great Britian: London.
[38] Mann K, Hiemke C, Lotz J, Schmidt LG, Lackner KJ, Bates DW.
Appropriateness of plasma level determinations for lithium and
valproate in routine care of psychiatric inpatients with aﬀective
disorders. J Clin Psychopharmacol 2006;26(6):671–3.
[39] Mann K, Hiemke C, Schmidt LG, Bates DW. Appropriateness of
therapeutic drug monitoring for antidepressants in routine psychiat-
ric inpatient care. Ther Drug Monit 2006;28(1):83–8.
[40] Chen P, Tanasijevic MJ, Schoenenberger RA, Fiskio J, Kuperman
GJ, Bates DW. A computer-based intervention for improving the
appropriateness of antiepileptic drug level monitoring. Am J Clin
Pathol 2003;119(3):432–8.
[41] Abookire SA, Karson AS, Fiskio J, Bates DW. Use and monitoring
of ‘‘statin’’ lipid-lowering drugs compared with guidelines. Arch
Intern Med 2001;161(1):53–8.
[42] Canas F, Tanasijevic MJ, Ma’luf N, Bates DW. Evaluating the
appropriateness of digoxin level monitoring. Arch Intern Med
1999;159(4):363–8.[43] Schoenenberger RA, Tanasijevic MJ, Jha A, Bates DW. Appropri-
ateness of antiepileptic drug level monitoring. JAMA
1995;274(20):1622–6.
[44] Chiquette E, Amato MG, Bussey HI. Comparison of an anticoag-
ulation clinic with usual medical care: anticoagulation control,
patient outcomes, and health care costs. Arch Intern Med
1998;158(15):1641–7.
[45] Levy G, Blachar A, Goldstein L, Paz I, Olsha S, Atar E, et al.
Nonradiologist utilization of American College of Radiology
Appropriateness Criteria in a preauthorization center for MRI
requests: applicability and eﬀects. AJR Am J Roentgenol
2006;187(4):855–8.
[46] Hadley JL, Agola J, Wong P. Potential impact of the American
College of Radiology appropriateness criteria on CT for trauma.
AJR Am J Roentgenol 2006;186(4):937–42.
[47] Choksi VR, Marn CS, Bell Y, Carlos R. Eﬃciency of a semiauto-
mated coding and review process for notiﬁcation of critical ﬁndings in
diagnostic imaging. AJR Am J Roentgenol 2006;186(4):933–6.
[48] Ambulatory Care Data from Health, United States, 2005. National
Center for Health Statistics, 2005.
[49] Health Care in America Trends in Utilization. Centers for Disease
Control, 2003.
[50] Shapiro JS, Kannry J, Lipton M, Goldberg E, Conocenti P, Stuard
S, et al. Approaches to patient health information exchange and
their impact on emergency medicine. Ann Emerg Med
2006;48(4):426–32.
[51] Sutcliﬀe KM, Lewton E, Rosenthal MM. Communication failures:
an insidious contributor to medical mishaps. Acad Med
2004;79(2):186–94.
[52] Petersen LA, Orav EJ, Teich JM, O’Neil AC, Brennan TA. Using a
computerized sign-out program to improve continuity of inpatient
care and prevent adverse events. Jt Comm J Qual Improv
1998;24(2):77–87.
[53] Helleso R, Lorensen M, Sorensen L. Challenging the information
gap–the patients transfer from hospital to home health care. Int J
Med Inform 2004;73(7–8):569–80.
[54] Foundation, M., The Personal Health Working Group. Final Report.
The Markle Foundation 2003. p. 1–58.
[55] Bourgeois FT, Valim C, Wei JC, McAdam AJ, Mandl KD. Inﬂuenza
and other respiratory virus-related emergency department visits
among young children. Pediatrics 2006;118(1):e1–8.
[56] Han YY, Carcillo JA, Venkataraman ST, Clark RS, Watson RS,
Nguyen TC, et al. Unexpected increased mortality after implemen-
tation of a commercially sold computerized physician order entry
system. Pediatrics 2005;116(6):1506–12.
[57] Koppel R, Metlay JP, Cohen A, Abaluck B, Localio AR, Kimmel
SE, et al. Role of computerized physician order entry systems in
facilitating medication errors. JAMA 2005;293(10):1197–203.
[58] Del Beccaro MA, Jeﬀries HE, Eisenberg MA, Harry ED. Comput-
erized provider order entry implementation: no association with
increased mortality rates in an intensive care unit. Pediatrics
2006;118(1):290–5.
[59] Arendt S, Barach P, Busis N, Goldberg R, Heyman J, Holly J,
et al. Computerized physician order entry systems and medication
errors (Letter to the Editor). J Am Med Assoc 2005;294(2):178–9.
[60] Lehmann CU, Kim GR. Computerized provider order entry and
patient safety. Pediatr Clin North Am 2006;53(6):1169–84.
[61] Horsky J, Kuperman GJ, Patel VL. Comprehensive analysis of a
medication dosing error related to CPOE. J Am Med Inform Assoc
2005;12(4):377–82.
